# US 2021/0275632 A1 · Method for treating kidney disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275632 A1
- Document ID: US20210275632A1
- Status: Published application
- Kind: A1
- Application number: 17/259,883
- Filed: 2019-07-12
- Published: 2021-09-09
- Earliest claimed: 2018-07-13
- Assignees: University of Miam
- Applicants: University of Miam
- Inventors: Alessia Fornoni; Sandra Merscher
- Web page: https://patentgrep.com/patent/US20210275632A1

## CPC

- A61K 38/1709: {from mammals}
- A61P 13/12: of the kidneys
- C07K 14/775: Apolipopeptides
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Disclosed herein is a method of treating or preventing renal disease in a subject suffering from Alport Syndrome, as well a method of treating or preventing chronic kidney disease. The method comprises administering to a subject in need thereof an effective amount of human apolipoprotein M.

## Claims

### Claim 1

A method of treating or preventing chronic kidney disease in a subject comprising administering human apolipoprotein M in an amount effective to treat chronic kidney disease in the subject.

### Claim 2

A method of treating or preventing renal disease in a subject suffering from Alport Syndrome comprising administering human apolipoprotein M to the subject in an amount effective to treat the renal disease in the subject.

### Claim 3

Human apolipoprotein M for use in the treatment or prevention of chronic kidney disease, wherein the human apolipoprotein M is administered in an amount and with a dosage regime effective to treat the chronic kidney disease.

### Claim 4

Human apolipoprotein M for use in the treatment or prevention of renal disease in a subject suffering from Alport Syndrome, wherein the human apolipoprotein M is administered in an amount and with a dosage regime effective to treat the renal disease.
